Mononucleosis risk factors: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:


==High-risk population==
==High-risk population==
===By Epidemiology===
*In underdeveloped countries, almost everyone is exposed to [[EBV|ebstein barr virus]] at a very young age; hence, mononucleosis exists mostly in developed countries.
===By Age===
*'''''Infants''''' become susceptible to [[EBV]] as soon as [[antibody|maternal antibody protection]] which is present at birth starts to disappears.  
*'''''Infants''''' become susceptible to [[EBV]] as soon as [[antibody|maternal antibody protection]] which is present at birth starts to disappears.  


*'''''Children''''' if infected with [[EBV]] usually remain asymptomatic and hence are indistinguishable from the other mild, brief illnesses of childhood. However, when the infection occurs during adolescence or young adulthood, it causes acute infectious mononucleosis 35% to 50% of the time.
*'''''Children''''' if infected with [[EBV]] usually remain asymptomatic and hence are indistinguishable from the other mild, brief illnesses of childhood. However, when the infection occurs during adolescence or young adulthood, it causes acute infectious mononucleosis 35% to 50% of the time.
*In underdeveloped countries, almost everyone is exposed at a very young age, so mononucleosis exists mostly in developed countries.


*Among '''''adults''''', increased risk of acquiring mononucleosis is observed among:
*Among '''''adults''''', increased risk of acquiring mononucleosis is observed among:
:*adolescents and young adults  
:*adolescents and young adults  
:*patients who have intimate contact with the saliva of an infected person
:*patients who have intimate contact with the saliva of an infected person
===By Immune system status===
*Any condition that '''''weakens the immune system''''' is a predisposing factor for the development of mononucleosis secondary to [[EBV|EBV infection]]
*For example: 
:*[[Diabetes]]
:*Following solid organ transplant
:*[[Chemotherapy]]
:*[[HIV]]


==References==
==References==

Revision as of 20:35, 29 February 2012

Mononucleosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Epidemiology and Demographics

Risk Factors

Causes

Differentiating Mononucleosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mononucleosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mononucleosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mononucleosis risk factors

CDC on Mononucleosis risk factors

Mononucleosis risk factors in the news

Blogs on Mononucleosis risk factors

Directions to Hospitals Treating Mononucleosis

Risk calculators and risk factors for Mononucleosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Majority of the population become infected with EBV at sometime during their lives with an estimated 90%-95% of adults demonstrating seropositivity by 21 years of age. Therefore, even individuals exposed to infected contacts have shown to be previously infected with EBV and hence are not at risk for the manifestation of mononucleosis.

However, once infected, the patient carries the virus for the rest of their life with the virus typically residing dormantly in the B lymphocytes. Independent infections of mononucleosis may be contracted multiple times, regardless of whether the patient is already carrying the virus dormantly.

Periodic reactivation of the virus may occur, during which time the patient is again infectious, but usually without any symptoms of illness. Therefore, in susceptible hosts under the appropriate environmental stressors, reactivation of the virus occurs to cause vague subclinical symptoms or remain mostly asymptomatic and diagnosed only by a positive serologic response. However, its imperative to note that during this phase the virus can spread to others.

High-risk population

By Epidemiology

  • In underdeveloped countries, almost everyone is exposed to ebstein barr virus at a very young age; hence, mononucleosis exists mostly in developed countries.

By Age

  • Children if infected with EBV usually remain asymptomatic and hence are indistinguishable from the other mild, brief illnesses of childhood. However, when the infection occurs during adolescence or young adulthood, it causes acute infectious mononucleosis 35% to 50% of the time.
  • Among adults, increased risk of acquiring mononucleosis is observed among:
  • adolescents and young adults
  • patients who have intimate contact with the saliva of an infected person

By Immune system status

  • Any condition that weakens the immune system is a predisposing factor for the development of mononucleosis secondary to EBV infection
  • For example:

References


Template:WikiDoc Sources